MAPKAPK5-AS1 and myositis disease: Recently, an increasing number of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) have been detected in IIMs, which are useful for the subclassification of phenotypes, predicting prognosis, and determining the management.